SeraCare 产品代理

产品分类 > 科研试剂 > SeraCare 产品代理

SeraCare 产品代理

SeraCare成立于1984年,30多年来一直是诊断检测行业值得信赖的合作伙伴和全球供应商,通过创新技术、质量控制、试剂和生物材料推动临床基因组学、分子和血清学诊断的发展。
SeraCare是一家通过ISO 13485认证的制造商,拥有先进的技术,包括完整的质量控制解决方案和强大的定制能力。SeraCare在参考标准方面处于领先地位,为基于NGS的测试提供商、IVD开发者和制造商以及临床实验室提供了精准医疗的承诺,并确保获得正确的结果
价格: 0.00

CONTROLS & REFERENCE MATERIALS

NGS

VALIDATION & QUALIFICATION MATERIALS

CELL CULTURE REAGENTS

PLASMA & SERUM DILUENTS & DERIVATIVES

KPL ANTIBODIES & CONJUGATES

KPL IMMUNOASSAY REAGENTS & KITS

PRODUCTS BY APPLICATION

CUSTOM SERVICES



Company History

Founded in 1984, SeraCare has been a trusted partner and worldwide supplier to the diagnostic testing industry for over 30 years, advancing the development of clinical genomics, molecular, and serological diagnostics with innovative technology, quality controls, reagents, and biological materials.

 

As an ISO 13485-certified manufacturer with advanced technology including a complete QC solution and robust customization capabilities, SeraCare is a leader in reference standards to enable the promise of precision medicine and ensure correct results for NGS-based test providers, IVD developers and manufacturers, and clinical laboratories.

 

Our roots

Our early history in the 1980s shows our devotion to supporting diagnostics professionals when SeraCare developed the industry’s first seroconversion panels. SeraCare’s focus on serology continued into the 1990s, where we established our leadership in plasmapheresis and increased our focus on IVD raw materials.

 

Through strategic acquisitions and consolidations, we expanded our R&D capabilities, crucial for evolving with the demands of the molecular diagnostics industry during the early 2000s. Our expertise allowed us to recognize the increasing clinical applications of next-generation sequencing (NGS) and companion diagnostics.

 

Continuing advancements

 

In 2012, Linden Capital Partners acquired SeraCare and introduced our CEO, Charlie Mamrak, and a trusted leadership team who continues to expand SeraCare’s specialties for the overall goal of improving the quality of life through a global understanding of disease. The continued development of extreme quality, improved efficiency, and focus on meeting the demands of the evolving IVD industry has brought SeraCare to its trusted state today, serving more than 90% of the world’s top IVD manufacturers with an increasing client base every day.

 

2013 brought a strategic addition to SeraCare's product portfolio with its acquisition of KPL, a trusted and experienced provider of primary and secondary antibodies for over 30 years, as well as reagents and reference materials needed for quality control applications. SeraCare also introduced its HIV-1 worldwide isolates in the AccuType portfolio, and launched our AccuPlex recombinant viral technology, enabling the development of custom recombinant controls and reference materials.

 

Supporting clinical genomics diagnostics

 

In 2015, we expanded our R&D facility in Gaithersburg, MD and launched a new clinical genomics business unit focused on the development of technologies and products to enable the safe and effective expansion of precision medicine-driven diagnostics. Understanding that our customers were transitioning to more data-intensive diagnostics methods and embracing new technologies, this business unit was formed to develop innovative solutions to support the accurate and precise use of advanced diagnostic platforms such as NGS and digital PCR.

 

Novel products for oncology, reproductive health, infectious disease, and inherited disease continually emerge from our pipeline in support of our clients' development and validation efforts for clinical genomics diagnostics. During this time, our Seraseq technology was introduced to develop high-quality NGS reference materials. Additional and ongoing developments include reference materials for the molecular analysis of hematological malignancies, solid tumors, and liquid biopsy. 2017 saw the launch of our powerful, yet easy-to-use iQ™ NGS QC Management software that makes it simple for clinical labs to ensure optimal NGS assay performance and maintain compliance.

 

 

A pillar of support for our clients

Today, with more than 150 employees, SeraCare continues to operate out of our corporate headquarters in Milford, MA. With three facilities in Milford and our R&D facility in Gaithersburg, MD, our company is dedicated to ongoing commercial development, manufacturing, and distribution of quality control products for the industry. With an extensive global network and over 30 years of experience, we will continue to serve the needs of our clients - IVD manufacturers, clinical laboratories, and life science researchers - as technology and client needs evolve.


上一个: seragold 产品代理
下一个: seqbiome 产品代理